Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Late buying fuels indices
Mon, 15 Jul Closing

Indian equity markets began the day's proceedings on a weak note and languished in the red in the morning session. However, in the subsequent hours, buying at lower levels pushed the indices above the dotted line. This buoyancy continued in the final trading hours as well and indices closed well into the green. While the BSE-Sensex today closed higher by 76 points, the NSE-Nifty closed higher by 22 points. The NSE-Nifty and the BSE Small Cap index also did well to notch gains of 1% each. Gains were largely seen in FMCG and banking stocks.

As regards global markets, Asian indices closed firm today while European indices have also opened in the green. The rupee was trading at Rs 59.90 to the dollar at the time of writing.

Most energy stocks closed firm today with the key gainers being Petronet LNG, Gujarat State Petronet and HPCL. As per a leading business daily, Hindustan Petroleum Corporation Limited (HPCL) will be entering into a joint venture (JV) with Shapoorji Pallonji to set up a terminal for import of liquid gas (LNG) on the Gujarat coast at a cost of about Rs 50 bn. This will be a 50:50 JV. Shapoorji is already developing a greenfield, direct berthing port in Junagadh district. According to the terms of the JV, a feasibility study will be carried out to establish technical and commercial viability of setting up a LNG import and regasification terminal of 5 m tonnes per annum capacity at the proposed port. The project is expected to be completed in around 3 and half years. This move is part of HPCL's strategy to bolster its LNG business. At present, domestic gas production in India is catering to only half the demand. Thus, there has been a beeline for setting up LNG terminals to capitalise on the opportunity.

Pharma stocks closed mixed today. While Wockhardt, Cipla and Ranbaxy found favour, Dr.Reddy's and Cadila Healthcare closed into the red. As per a leading business daily, Cipla plans to fuel its growth plans by expanding in Africa. In this regard, Cipla already has a big share in the South African pharmaceutical market as it will be acquiring local pharma company Cipla Medpro. The two have a supply agreement since 2005. But plans on the anvil include expanding in other African markets as well. Priority will especially be on Nigeria and the East African region. The company' strength lies in the anti-retrovirals (ARVs) and anti-malarial space. Growth will largely be driven by volumes especially since margins in these markets will be on the lower side.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Late buying fuels indices". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.